CDTX — CIDARA THERAPEUTICS INC

Ownership history in Aberdeen Group plc  ·  3 quarters on record

This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in CIDARA THERAPEUTICS INC (CDTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2025 Q3)
Avg. % of fund
0.02%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 177,523 -82,393 -31.7% 0.03% $17.0M —
2025 Q2 ADDED 259,916 +139,037 +115.0% 0.02% $12.7M —
2025 Q1 INITIATED 120,879 — — 0.01% $2.6M —
% of Fund (quarterly)

Other funds also holding CDTX

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 13.89% Vivo Capital, LLC 3Y 7Y 13.66% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 13.37% Beryl Capital Management LLC 3Y 7Y 11.69% SUPERSTRING CAPITAL MANAGEMENT LP 10.06% FNY Investment Advisers, LLC 3Y 7Y 9.07% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 8.12% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 7.62% Sand Grove Capital Management LLP 3Y 7Y 6.05% Chicago Capital Management, LLC 3Y 7Y 5.56%
← Back to Aberdeen Group plc Holdings